However, it was demonstrated that an antagonist of CXCR4, BL-8040, determined the apoptosis of AML cells in vitro and in vivo and induced the robust mobilization of AML blasts from the bone marrow (BM). Here, CXCR4 is linked to acute myeloid leukemia.